{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:44:57Z","timestamp":1791405897165,"version":"4.3.3"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG3C0391"],"award-info":[{"award-number":["CMRPG3C0391"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG3D005"],"award-info":[{"award-number":["CMRPG3D005"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG3D009"],"award-info":[{"award-number":["CMRPG3D009"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-100-TP2-B02-4"],"award-info":[{"award-number":["AS-100-TP2-B02-4"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["102-2314-B-182A-087-MY3"],"award-info":[{"award-number":["102-2314-B-182A-087-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bbi.2014.09.011","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T11:36:43Z","timestamp":1411904203000},"page":"121-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"special_numbering":"C","title":["Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model"],"prefix":"10.1016","volume":"44","author":[{"given":"Kuo-Hsuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2014.09.011_b0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1582-4934.2010.01011.x","article-title":"Early defect of transforming growth factor beta1 formation in Huntington\u2019s disease","volume":"15","author":"Battaglia","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbi.2014.09.011_b0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2014.09.011_b0015","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2014.09.011_b0020","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington\u2019s disease","volume":"32","author":"Bouchard","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2014.09.011_b0025","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0896-6273(03)00766-9","article-title":"Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain","volume":"40","author":"Brionne","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2014.09.011_b0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2014.09.011_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/scdb.2001.0290","article-title":"Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders","volume":"13","author":"Carmeliet","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbi.2014.09.011_b0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.STR.0000046764.57344.31","article-title":"Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke","volume":"34","author":"Castellanos","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.bbi.2014.09.011_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington\u2019s disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2014.09.011_b0050","doi-asserted-by":"crossref","first-page":"e46492","DOI":"10.1371\/journal.pone.0046492","article-title":"Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington\u2019s disease patients","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2014.09.011_b0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2014.09.011_b0060","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbi.2014.09.011_b0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2014.09.011_b0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbrc.2004.02.143","article-title":"Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix","volume":"316","author":"Dang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2014.09.011_b0075","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.51.6.1576","article-title":"Cerebral blood flow velocity decreases during cognitive stimulation in Huntington\u2019s disease","volume":"51","author":"Deckel","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2014.09.011_b0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nrg1690","article-title":"Therapeutics development for triplet repeat expansion diseases","volume":"6","author":"Di Prospero","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbi.2014.09.011_b0085","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/mt.2013.132","article-title":"Dose-dependent neuroprotection of VEGF(1)(6)(5) in Huntington\u2019s disease striatum","volume":"21","author":"Ellison","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbi.2014.09.011_b0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2014.09.011_b0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/gb-2005-6-3-210","article-title":"Connecting the dots in Huntington\u2019s disease with protein interaction networks","volume":"6","author":"Giorgini","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbi.2014.09.011_b0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2014.09.011_b0105","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.1563-05.2005","article-title":"A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia","volume":"25","author":"Gu","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2014.09.011_b0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1073634","article-title":"S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death","volume":"297","author":"Gu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbi.2014.09.011_b0115","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/122.9.1667","article-title":"Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington\u2019s disease","volume":"122","author":"Harris","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2014.09.011_b0120","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/jnnp.55.11.1018","article-title":"Reduced regional cerebral blood flow in Huntington\u2019s disease studied by SPECT","volume":"55","author":"Hasselbalch","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2014.09.011_b0125","first-page":"127","article-title":"Matrix metalloproteinase (MMP)","volume":"185","author":"Hornebeck","year":"1991","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"10.1016\/j.bbi.2014.09.011_b0130","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.162.9.5041","article-title":"Cutting edge: generation of IL-18 receptor-deficient mice. evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2014.09.011_b0135","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington\u2019s disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2014.09.011_b0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12035-009-8097-5","article-title":"Targeting glial cells to elucidate the pathogenesis of Huntington\u2019s disease","volume":"41","author":"Hsiao","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2014.09.011_b0145","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2014.09.011_b0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/cyto.2002.2005","article-title":"Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis","volume":"20","author":"Ilzecka","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2014.09.011_b0155","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant Huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2014.09.011_b0160","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.neurobiolaging.2011.08.011","article-title":"Microglia-inhibiting activity of Parkinson\u2019s disease drug amantadine","volume":"33","author":"Kim","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2014.09.011_b0165","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2013.108","article-title":"Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model","volume":"21","author":"Krakora","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbi.2014.09.011_b0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1152\/jappl.1999.86.1.260","article-title":"Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain","volume":"86","author":"Kuo","year":"1999","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbi.2014.09.011_b0175","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jnr.21072","article-title":"Ectopic expression of phospho-Smad2 in Alzheimer\u2019s disease: uncoupling of the transforming growth factor-beta pathway?","volume":"84","author":"Lee","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2014.09.011_b0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2008.12.181","article-title":"PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia","volume":"380","author":"Lee","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2014.09.011_b0185","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2014.09.011_b0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/exer.2001.1054","article-title":"Regulation of MMP-9 production by human corneal epithelial cells","volume":"73","author":"Li","year":"2001","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbi.2014.09.011_b0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models ofHuntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbi.2014.09.011_b0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington\u2019s disease","volume":"250","author":"Lin","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2014.09.011_b0205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2014.09.011_b0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajmg.b.30223","article-title":"Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington\u2019s disease","volume":"139B","author":"Maglione","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatric Genet."},{"key":"10.1016\/j.bbi.2014.09.011_b0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2014.09.011_b9000","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","article-title":"Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease","volume":"67","author":"Miller","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2014.09.011_b0220","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington\u2019s disease","volume":"117","author":"Moller","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2014.09.011_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JHD-130050","article-title":"Large genetic animal models of Huntington\u2019s disease","volume":"2","author":"Morton","year":"2013","journal-title":"J Huntington\u2019s Dis."},{"key":"10.1016\/j.bbi.2014.09.011_b0230","doi-asserted-by":"crossref","first-page":"RRN1205","DOI":"10.1371\/currents.RRN1205","article-title":"Optimization of an HTRF assay for the detection of soluble mutant Huntingtin in human buffy coats: a potential biomarker in blood for Huntington disease","volume":"2","author":"Moscovitch-Lopatin","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.bbi.2014.09.011_b0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2007.09.002","article-title":"Altered plasma cytokine levels in Alzheimer\u2019s disease: correlation with the disease progression","volume":"114","author":"Motta","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbi.2014.09.011_b0240","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/01.wnr.0000127073.66692.8f","article-title":"Autophagosome-like vacuole formation in Huntington\u2019s disease lymphoblasts","volume":"15","author":"Nagata","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbi.2014.09.011_b0245","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2007.06.006","article-title":"Expression of interleukin-18 is increased in the brains of Alzheimer\u2019s disease patients","volume":"30","author":"Ojala","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2014.09.011_b0250","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2014.09.011_b0255","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1152\/japplphysiol.00318.2002","article-title":"Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia","volume":"93","author":"Pichiule","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbi.2014.09.011_b0260","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejphar.2012.10.026","article-title":"Late onset vascular dysfunction in the R6\/1 model of Huntington\u2019s disease","volume":"698","author":"Rahman","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2014.09.011_b0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-006-0562-6","article-title":"Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer\u2019s disease patients","volume":"27","author":"Rota","year":"2006","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbi.2014.09.011_b0270","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1016\/S0021-9258(18)98977-5","article-title":"Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes","volume":"266","author":"Salo","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2014.09.011_b0275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbi.2014.09.011_b0280","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2014.09.011_b0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbi.2014.09.011_b0290","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbi.2014.09.011_b0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1097-2765(00)80154-9","article-title":"VEGF gene delivery to muscle: potential role for vasculogenesis in adults","volume":"2","author":"Springer","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbi.2014.09.011_b0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntington\u2019s disease: translational strategies using antioxidants","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2014.09.011_b0305","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington\u2019s disease","volume":"72","author":"Tai","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2014.09.011_b0310","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/156720506779025297","article-title":"A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models","volume":"3","author":"Tesseur","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbi.2014.09.011_b0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2014.09.011_b0320","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2014.09.011_b0325","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/1073858405280639","article-title":"The ubiquitin \u2013 proteasome system in Huntington\u2019s disease","volume":"11","author":"Valera","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbi.2014.09.011_b0330","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/exnr.1996.0200","article-title":"TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson\u2019s disease in ventricular cerebrospinal fluid","volume":"142","author":"Vawter","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2014.09.011_b0335","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/awh489","article-title":"Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage","volume":"128","author":"Wang","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2014.09.011_b0340","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.1104836108","article-title":"Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans","volume":"108","author":"Warner-Schmidt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbi.2014.09.011_b0345","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant Huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression","volume":"122","author":"Weiss","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2014.09.011_b0350","doi-asserted-by":"crossref","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington\u2019s disease","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.bbi.2014.09.011_b0355","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.4049\/jimmunol.161.11.6368","article-title":"Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis","volume":"161","author":"Wildbaum","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2014.09.011_b0360","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00004647-200208000-00008","article-title":"Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury","volume":"22","author":"Yatsiv","year":"2002","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbi.2014.09.011_b0365","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuroscience.2013.11.038","article-title":"Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson\u2019s disease","volume":"258","author":"Yue","year":"2014","journal-title":"Neuroscience"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114004644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114004644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:38:05Z","timestamp":1760168285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159114004644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":74,"alternative-id":["S0889159114004644"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2014.09.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2014.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}